Heart Failure
MULTAQ(R) (dronedarone) for Atrial Fibrillation or Atrial Flutter Now Available in the United States
Published in Medical Letter on the CDC and FDA, August 16th, 2009
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced that MULTAQ (dronedarone) 400 mg Tablets is now available in pharmacies in the United States. MULTAQ is an anti-arrhythmic drug indicated to reduce the risk of cardiovascular hospitalization in patients with paroxysmal or persistent atrial fibrillation (AF) or atrial flutter (AFL), with a recent episode of AF/AFL and associated cardiovascular risk factors (i.e., age >70, hypertension, diabetes, prior cerebrovascular accident, left atrial diameter greater than or equal to 50 mm or left ventricular ejection fraction [LVEF] <40%), who are in sinus rhythm or who will be cardioverted.
MULTAQ was recently approved...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- American Associates, Ben-Gurion University of the Negev
1 in 6 health workers won't report in flu pandemic -- study by Ben-Gurion U. researchers - New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Early detection and quick response are key to defense against anthrax attack - SAGE Publications
Bioterrorism and disaster preparedness explored in special issue of Medical Decision Making - The Company of Biologists
Stress signals link pre-existing sickness with susceptibility to bacterial infection - Cyberonics, Inc.
Cyberonics Provides Update on Depression Post-Approval Study - Learning Disability
Mayo Researchers Find Anesthesia Not Harmful for Babies During Birth Process - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
